Visceral leishmaniasis – from a case-report with retinal haemorrhages
Keywords:
visceral Leishmaniasis, Kala-azar, diagnostic difficulties, retinal haemorrhagesAbstract
Visceral Leishmaniasis (VL) is a worldwide infection including
multiple clinical syndromes, increasingly recognized as an opportunistic infection, associated with immunosuppression conditions,
particularly HIV infection. Fever, constitutional symptoms, splenomegaly and pancytopenia are the most characteristic features.
Ocular involvement with intra-retinal haemorrhage is very rare.
Diagnosis can be difficult as parasite identification is not always
possible, serological tests have suboptimal sensitivity, and molecular biology techniques, like Polymerase Chain Reaction, are
often unavailable in clinical practice.
Except in India, antimonial drugs have been first choice therapy,
although there is a trend towards Amphotericin in immunocompromised patients.
In this case-report we present a 35-years-old patient, resident
in an endemic area of the disease, HIV-seronegative, with a longstanding condition of constitutional symptoms, fever, massive
splenomegaly and pancytopenia. Attempts to isolate the parasite
were of no avail; there was no evidence of another disease,
and serological tests results for Leishmania were positive and
strongly suggestive of active infection. Just before beginning
antimony treatment, the patient mentioned blurred vision and
an ophthalmologic examination showed bilateral retinal haemorrhages. Full ocular and clinic laboratorial recovery ensued along
the treatment course.
We report this case due to the unusual ocular lesions in VL
and complexity issues concerning the diagnosis. With this paper
we also want to remind that, in spite of its rarity in developed
countries, VL should not be underestimated in a patient with a
suggestive clinical condition.
Downloads
References
Murray HW. Kala-Azar - Progress against a neglected disease. N Engl J Med 2002; 347: 1793-1794.
Jeronimo S, Sousa A, Pearson R. Leishmania Species: Visceral (Kala-azar), Cutaneous and Mucocutaneous Leishmaniasis. In Mandell, Douglas and Bennett´s Principles of Infectious Diseases, 6th Ed. Philadelphia. Churchill Livingstone 2005; 119: 3145-3156.
Leder K, Weller P. Epidemiology and clinical manifestations of leishmaniasis; Diagnosis of leishmaniasis; Treatment and prevention of leishmaniasis. Uptodate 2008.
Choi CM, Lerner EA. Leishmaniasis as an Emerging Infection. JID Symposium Proceedings 2001; 6: 175-182.
Herwaldt L. Barbara; Leismaniasis; Fauci, Braunwald, Kasper, Hauser, Longo, Jameson, Loscalzo (Eds.); In Harrison`s Principles of Internal Medicine 17th edition, p1296-1300.
Desjeux P, Alvar J. Leishmania/HIV co-infections: epidemiology in Europe. Ann Trop Med Parasitol 2003; 97 (suppl 1): S3-S15.
Paredes R, Munoz J, Diaz I et al. Leishmaniasis in HIV infection. J Post-graduate Med 2003; 49: 39-49.
Guerin PJ, Olliaro P, Sundar S et al. Visceral leishmaniasis: current status of control, diagnosis, and treatment and a proposed research and development agenda. Lancet Infect Dis 2002; 2: 494-501.
Pintado V, Martín-Rabadán P, Rivera ML et al. Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected patients. Medicine 2001; 80: 54-73.
Klotz SA, Penn CC, Negvesky GJ et al. Fungal and Parasitic Infections of the Eye. Clinical Microbiology Reviews 2000;13: 662–685.
De Cock KM, Rees PH, Klauss V et al. Retinal hemorrhages in Kala Azar. Am J Trop Med Hyg 1982; 31(5): 927-930.
Montero JA, Ruiz-Moreno JM, Sanchis E. Intraretinal hemorrhage associated with leishmaniasis. Ophthalmic Surg Lasers Imaging 2003; 34(3); 212-214.
Abboud IA, Ragab HAA, Hanna LS. Experimental ocular leishmaniasis. Brit J Ophthal 1970);54: 256-262.
Pal S, Aggarwal G, Haldar A et al. Diagnosis of symptomatic kala-azar by polymerase chain reaction using patient`s blood. Med Sci Monit 2004; 10(1): MIT 1-5.
Medrano FJ, Canavate C, Leal M et al. The role of serology in the diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type-1. Am J Trop Med Hyg 1998; 59(1): 155-162.
Marques N, Cabral S, Sá R, et al. Leishmaniose visceral e infecção por vírus da imunodeficiência humana, na era da terapêutica anti-retrovírica de alta eficácia. Acta Med Port 2007; 20: 291-298
Piarroux R, Gambarelli F, Dumon H et al. Comparison of PCR with direct examination of bone marrow aspiration, myeloculture, and serology for diagnosis of visceral leishmaniasis. J Clin Microbiol 1994; 32(3): 746-749.
Braz RF, Nascimento et, Martins DR et al: The sensitivity and specificity of Leishmania chagasi recombinant K39 antigen in the diagnosis of American visceral leishmaniasis and in differentiating active from subclinical infection. Am J Trop Med Hyg 2002;67:344-348
Md Gulam Musawwir Khan, Mohammad Shafiul Alam, Milka P Podder, Makoto Itoh, Kazi M Jamil, Rashidul Haque and Yukiko Wagatsuma: Evaluation of rK-39 strip test using urine for diagnosis of visceral leishmaniasis in an endemic area in Bangladesh. Parasites & Vectors 2010, 3:114.
Murray HW, Berman J, Davies C et al. Advances in leishmaniasis. Lancet 2005; 366: 1561-1577.
Sundar S, More DK, Singh MK et al. Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clin Infect Dis 2003; 31: 1104-1106.
Chappuis F, Sundar S, Hailu A et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol 2007; 5(11): 873-882.
Sundar S, Jha TK, Thakur CP et al. Oral miltefosine for Indian visceral leishmaniasis. N Engl J Med 2002; 347: 1739-1746.
Bhattacharya SK, Sinha PK, Sundar S et al. Phase 4 trial of miltefosine for the treatment of visceral leishmaniasis. J Infect Dis 2007; 196: 591.
Sindermann H, Engel KR, Fisher C et al. Oral miltefosine for leishmaniasis in immunocompromised patients: compassionate use in 39 patients with HIV infection. Clin Infect Dis 2004; 39:1520-1523.
Herwaldt BL, Berman JD. Recommendations for Treating Leishmaniasis with Sodium Stibogluconate (Pentostam) and Review of Pertinent Clinical Studies. Am J Trop Med Hyg 1992; 46(3): 296-306
Additional Files
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna